search

The Real Deal Logo

Trending

Lawmakers reach sweeping housing deal with “good cause eviction,” new 421aLawmakers reach sweeping housing deal with “good cause eviction,” new 421aHGTV’s “Mr. Flip It” gets four years in jail for $10M fraudHGTV’s “Mr. Flip It” gets four years in jail for $10M fraudMarty Burger’s new venture sputters on takeoffMarty Burger’s new venture sputters on takeoff“Investing before the ‘all clear’ sign”: Jon Gray on Blackstone’s $10B apartment deal“Investing before the ‘all clear’ sign”: Jon Gray on Blackstone’s $10B apartment deal
Tech
New York

NYC biotech developments garner buzz

alternate text
From left: renderings of BioBAT in Brooklyn and Alexandria Center for Life Science

Sign Up for the undefined Newsletter

The construction of two new biotechnology centers in the city is spurring hope that New York City could become a hub of scientific activity, according to the New York Times. The Alexandria Center for Life Science, a $200 million, 310,000-square-foot commercial laboratory developed by Alexandria Real Estate Equities, sits on the corner of 29th Street and First Avenue. While the facility has only signed one tenant so far — Eli Lilly and Company, a pharmaceutical company that has taken 90,000 square feet — Alexandria founder Joel Marcus said he’s planning to build two new towers nearby. If the two additions are completed, the complex could reach 1.13 million square feet. The other commercial lab, which has only completed its first phase of construction, is the planned 1.8 million-square-foot BioBAT complex in the Brooklyn Army Terminal. The biotech center, which is being developed through a partnership between the New York City Economic Development Corporation and the SUNY Downstate Medical Center, doesn’t have any tenants signed on yet. [NYT]

Tags
SunyTechnology